Today's PR show us how the company is going to be presenting to potential partners and investors next week. We have the ONLY drug that does anything significant against OM, and it's a mammoth market. Remember, it's not just head and neck cancer patients who get OM, some people with other cancers do also. IPIX ise just studying this in HNC.

The scum will try to focus the conversation today on provoking anger.

Please ignore them. They know we've been on to their game for years.